| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 244,292 | 244,461 | 246,894 | 229,429 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 244,461 | 246,894 | 229,429 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 194,886 | 119,379 | 168,267 | 171,166 | | Non Recurring | (42,793) | 42,793 |
-
|
-
| | Others | 56,974 | 53,782 | 54,097 | 56,773 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,523 | 28,507 | 24,530 | 1,490 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 3,479 | | Earnings Before Interest And Taxes | 35,225 | 28,507 | 24,530 | 4,969 | | Interest Expense | 1,516 | 1,564 | 1,622 | 1,657 | | Income Before Tax | 33,709 | 26,943 | 22,908 | 3,312 | | Income Tax Expense | 8,985 | 6,811 | 5,619 | (1,315) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 24,724 | 20,132 | 17,289 | 4,627 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,724 | 20,132 | 17,289 | 4,627 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,724 | $20,132 | $17,289 | $4,627 |
|
0.10% Nasdaq 
Income Statement
